Key result
Stilbenoid trimers TS2 and TS3 demonstrated potential as SIRT1 enzyme inhibitors with QM/MM-GBSA binding energies of -58.99 and -43.38, respectively, suggesting utility as anticancer agents.
Stilbenoid trimers TS2 and TS3 show potential as SIRT1 enzyme inhibitors in computational models, suggesting a possible role as anticancer agents.
Answers are grounded in this paper and cite their sources.
Warrants experimental validation before any therapeutic consideration; leaves open clinical translation of these stilbenoids as SIRT1 inhibitors.
) using the Quantum Mechanics/generalized Born Surface Area (QM/MM-GBSA) method shows the results of 1NS: -31.52 ± 0.39, TS2: -58.99 ± 0.34, and TS3: -43.38 ± 0.35. These results indicate that the TS2 and TS3 compounds have good potential as inhibitors of the SIRT1 enzyme. Additionally, the amino acid residues were responsible for the inhibition mechanism through hydrogen bond interactions at the molecular level, including ASP22, PHE91, PRO11, ILE165, ASP166, and VAL230. The observations made in this study provide theoretical information for exploring the stilbenoid trimers as anticancer agents by targeting the SIRT1 enzyme.
No takes yet. Share an insight, caveat, or question.
Abdjan et al. (2021) studied Cancer. Stilbenoid trimers (TS2 and TS3) was evaluated on SIRT1 enzyme inhibition potential (QM/MM-GBSA binding energy). Stilbenoid trimers TS2 and TS3 demonstrated potential as SIRT1 enzyme inhibitors with QM/MM-GBSA binding energies of -58.99 and -43.38, respectively, suggesting utility as anticancer agents.
Synapse has enriched 10 related papers. Consider them for comparative context: